Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Galera Therapeutics, Inc. (GRTX) had Return on Equity of 12.81% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-18.96M |
|
-- |
|
-- |
|
$20.16M |
|
$-20.16M |
|
$1.00M |
|
$-19.16M |
|
$-19.16M |
|
$-18.96M |
|
$-18.96M |
|
$-18.96M |
|
$-18.96M |
|
$-20.16M |
|
$-20.14M |
|
54.63M |
|
54.63M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$10.00M |
|
-- |
|
$0.10M |
|
$10.10M |
|
$1.67M |
|
-- |
|
$156.48M |
|
$158.14M |
|
$-148.04M |
|
$-148.04M |
|
$-148.04M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-12.14M |
|
$-0.05M |
|
$2.22M |
|
$18.26M |
|
$8.29M |
|
$-9.97M |
|
$2.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
12.81% |
12.81% |
|
-187.67% |
|
12.81% |
|
$-1.96 |
|
$-0.22 |
|
$-0.22 |
|